These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8514974

  • 1. Modulation of pituitary insulin-like growth factor-I bindings in rats bearing somatomammotrophic tumors.
    Matsuo K, Yamashita S, Namba H, Niwa M, Harakawa S, Izumi M, Nagataki S.
    J Endocrinol Invest; 1993 Mar; 16(3):189-94. PubMed ID: 8514974
    [Abstract] [Full Text] [Related]

  • 2. Thyroid hormone regulates rat pituitary insulin-like growth factor-I receptors.
    Matsuo K, Yamashita S, Niwa M, Kurihara M, Harakawa S, Izumi M, Nagataki S, Melmed S.
    Endocrinology; 1990 Jan; 126(1):550-4. PubMed ID: 2152872
    [Abstract] [Full Text] [Related]

  • 3. Differential tissue regulation of the insulin-like growth factors in rats bearing the MStT/W15 pituitary tumor.
    Gelato MC, Vassalotti J, Spatola E, Rutherford C, Marsh K, Carlson HE.
    Neuroendocrinology; 1992 Dec; 56(6):765-74. PubMed ID: 1369583
    [Abstract] [Full Text] [Related]

  • 4. Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation.
    Fagin JA, Brown A, Melmed S.
    Endocrinology; 1988 May; 122(5):2204-10. PubMed ID: 3359980
    [Abstract] [Full Text] [Related]

  • 5. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.
    Ramos S, Goya L, Alvarez C, Martín MA, Pascual-Leone AM.
    J Endocrinol; 2001 Apr; 169(1):111-22. PubMed ID: 11250652
    [Abstract] [Full Text] [Related]

  • 6. Binding and action of insulin-like growth factor I in pituitary tumor cells.
    Yamasaki H, Prager D, Gebremedhin S, Moise L, Melmed S.
    Endocrinology; 1991 Feb; 128(2):857-62. PubMed ID: 1989866
    [Abstract] [Full Text] [Related]

  • 7. Autoregulation of pituitary growth hormone messenger ribonucleic acid levels in rats bearing transplantable mammosomatotrophic pituitary tumors.
    Yamashita S, Slanina S, Kado H, Melmed S.
    Endocrinology; 1986 Mar; 118(3):915-8. PubMed ID: 3948780
    [Abstract] [Full Text] [Related]

  • 8. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.
    Priego T, Granado M, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.
    J Endocrinol; 2003 Oct; 179(1):107-17. PubMed ID: 14529571
    [Abstract] [Full Text] [Related]

  • 9. Renal expression of IGF I in hypersomatotropic states.
    Miller SB, Rotwein P, Bortz JD, Bechtel PJ, Hansen VA, Rogers SA, Hammerman MR.
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F251-7. PubMed ID: 1696787
    [Abstract] [Full Text] [Related]

  • 10. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K, Del Rincon JP, Kim DS, Itoh E, Nass R, Coschigano KT, Kopchick JJ, Thorner MO.
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [Abstract] [Full Text] [Related]

  • 11. The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I, a potent IGF analogue, on growth hormone and IGF-binding protein secretion from cultured rat anterior pituitary cells.
    Simes JM, Wallace JC, Walton PE.
    J Endocrinol; 1991 Jul; 130(1):93-9. PubMed ID: 1715381
    [Abstract] [Full Text] [Related]

  • 12. A transforming growth factor-alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation.
    Finley EL, Ramsdell JS.
    Endocrinology; 1994 Jul; 135(1):416-22. PubMed ID: 8013379
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic octreotide treatment on GH secretory dynamics and tumor growth in rats bearing an ectopic somatotroph (GC) tumor.
    Mounier F, Bluet-Pajot MT, Viollet C, Bertherat J, Timsit J, Tannenbaum GS, Epelbaum J.
    J Neuroendocrinol; 1995 Aug; 7(8):645-51. PubMed ID: 8704739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro effects of somatostatin on the growth hormone-insulin-like growth factor axis in orange-spotted grouper (Epinephelus coioides).
    Wang B, Jia J, Yang G, Qin J, Zhang C, Zhang Q, Sun C, Li W.
    Gen Comp Endocrinol; 2016 Oct 01; 237():1-9. PubMed ID: 26526981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
    Kovacs M, Kineman RD, Schally AV, Flerko B, Frohman LA.
    J Neuroendocrinol; 2000 Apr 01; 12(4):335-41. PubMed ID: 10718930
    [Abstract] [Full Text] [Related]

  • 18. Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone.
    Fagin JA, Fernandez-Mejia C, Melmed S.
    Endocrinology; 1989 Nov 01; 125(5):2385-91. PubMed ID: 2791994
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D, Walker JL, Adam E, Moatsstaats B, Mulumba N, Ketelslegers JM, Underwood LE.
    Endocrinology; 1992 Jun 01; 130(6):3257-64. PubMed ID: 1375898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.